In a largely consolidated global transcriptomics technologies market, majority market share is held by a few large players, as per a new report by Transparency Market Research (TMR). Large companies are focused on organic growth route to further bolster their position.
Key companies to name in the global transcriptomics technologies market are Affymetrix Inc., F-Hoffmann La Roche Ltd., Life Technologies Corporation, Agilent Technologies, Illumina Inc., and Thermo Fisher Scientific.
As per the TMR study, the global transcriptomics technologies market is predicted to clock a CAGR of 15.90% for the forecast period between 2013 and 2019, for the market to be worth US44.6 bn by the end of 2019. The demand in the market translated into a revenue of US$1.65 bn in 2012. By technology, polymerase chain reaction (PCR) segment is anticipated to continue to lead vis-à-vis revenue until 2019. PCR offers benefits of process efficiency, greater amplification, and better precision over other technology segments. This, along with wider application areas, versatility in approach, and incessant product modification are some other attributes of PCR. On the other hand, next generation sequencing (NGS) segment is poised to display a significant growth rate over the forecast period.
Geography-wise, North America is predicted to continue to dominate the global transcriptomics market until 2019. The region being home to several biotech companies along with well-established infrastructure account for its dominance.
Efforts of Pharmaceutical Companies to Develop Personalized Medicine Fuels Growth
The global transcriptomics technologies market is poised for a notable growth in the near future, says the lead author of the study. Transcriptomics research involves studying anatomy and physiology of RNA in a cell. At present, transcriptome analysis of several organisms is carried out using next-generation sequencing platforms in the initial phase followed by gene regulation technologies, polymerase chain reactions, and microarrays in the latter part.
The rising interest of pharmaceutical companies in the development of personalized and targeted therapeutics is stoking demand for identification of disease-specific biomarkers. This, in turn is aiding the growth of transcriptomics technologies market. In addition, increasing R&D investments for biological research along with improvement of healthcare infrastructure are providing a fillip to this market. The fusion of these technologies is used for clinical diagnosis of diseases, drug discovery, medical research, and others. Transcriptomics research allows development of novel diagnostics and therapeutics and further advancement of existing treatment for medical conditions.
Generation of Massive Volume of Data from Research, Academia Stokes Demand
Growing focus on the development of bioinformatics tools and services is another key factor boosting the transcriptomics technologies market. The massive volume of research data generated as a result of research and development pursuits in the corporate, academic, and research sectors has created a pressing need to develop sophisticated and reliable software. This is creating demand for advanced bioinformatics tools to manage massive volume of research data.
Consistent development in applications of transcriptomics technologies to offer added value to users is boosting the growth of transcriptomics technologies market. For example, the utilization of transcriptomics technologies benefits pharmaceutical and biotechnology fields among others.
However, on the downside, unavailability of avant-garde equipment needed for biological computation, unavailability of services essential to analyze complex information, and an overall dearth of technical personnel are hindrances to the growth of transcriptomics technologies market.
The review presented is based on the findings of a TMR report, titled “Transcriptomics Technologies Market (Technology - Microarrays, PCR, Gene Regulation and Next Generation Sequencing; Application – Clinical Diagnostics, Drug Discovery and Research, Bioinformatics, and Comparative Transcriptomics Studies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”
The global transcriptomics technologies market is segmented as follows;
Transcriptomics Technologies Market, by Technology
- Polymerase Chain Reaction (PCR)
- Gene Regulation Technologies
- Next Generation Sequencing (NGS)
Transcriptomics Technologies Market, by Application
- Clinical Diagnostics
- Drug Discovery and Research
- Comparative Transcriptomics Studies
Transcriptomics Technologies Market, by Geography
- North America
- Rest of the World (RoW)
Browse : Our new press releases https://www.transparencymarketresearch.com/pressrelease/global-transcriptomics-technologies-market.htm
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Transparency Market Research
90 State Street,
Albany NY - 12207
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC